The Department of Drug Administration (Ministry of Health) has just sent an official dispatch to the Departments of Health of provinces and cities to request a nationwide recall of hard capsules Locobile-200 (lot No: WLD21003E, date of production: February 4, 2021, Expiry date: February 3, 2024), manufactured by M/s Windlas Biotech Limited (India), imported by A My Pharmaceutical Co., Ltd (Ward 9, Tan Binh District, Ho Chi Minh City). The reason is that this product violates level 3 quality standards.
Packaging of hard capsules Locobile - 200
Hard capsules Locobile-200 are indicated for pain relief and symptomatic treatment in pathologies such as: osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute attacks and menstrual pains.
The Department of Drug Administration requires the Departments of Health of the provinces and cities directly under the Central Government and health sectors to notify the drug using businesses to recall of the batch of drugs that do not meet the above quality standards. Publish information about the drug recall decision on the Department's website, inspect and supervise the units implementing this notice.
Request A My Pharmaceutical Co., Ltd. to coordinate with drug supplier and distributor to send notices and recall all batches of drugs that do not meet the above quality standards.
